Patient Reported Outcomes over Time in 25,988 Axial Spondyloarthritis Patients Initiating Treatment with 1 st , 2 nd bor 3 rd bTNF Inhibitor in Clinical Practice – Is PRO Remission Achieved? Results from the EuroSpA Collaboration

Lykke Midtbøll Ørnbjerg, J. Askling, A. G. Loft, M. J. Nissen, H. Mann, H. Direskeneli, F. Iannone, J. Sexton, D. Nordström, M. J. Santos, C. Codreanu, M. Pombo-Suarez, Z. Rotar, B. Gudbjornsson, I. van der Horst-Bruinsma, U. Lindström, A. Ciurea, K. Pavelka, N. Yilmaz, E. GremeseE. Kristianslund, A. M. Hokkanen, A. Barcelos, R. Ionescu, C. Sánchez-Piedra, M. Tomsic, A. J. Geirsson, M. van de Sande, G. Macfarlane, Cecilie Cornelia Heegaard Brahe, Merete Lund Hetland, Mikkel Østergaard

Original languageEnglish
Article number1083
JournalArthritis & Rheumatology
Volume71
Issue numberS10
Number of pages5
ISSN1537-2960
Publication statusPublished - 2019

Cite this